AKOS024836912
AKOS024836912 is a EGFR-EGF interaction inhibitor. AKOS024836912 is applicable to research related to non-small cell lung cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1705763-81-0
- Fòrmula: C18H23N5O2
- Peso molecular:341.41
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas EGFR
More
Actividad biológica
AKOS024836912 exhibits higher binding affinity to the EGF-binding cleft of EGFR (PDB ID: 1NQL) than its parent compound Dacomitinib (HY-13272), with a rearrangement score of -114.109[1].
AKOS024836912 inhibits the interaction between EGFR (PDB ID: 1NQL) and EGF, with a PatchDock score of 6115[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 1705763-81-0
-
Peso molecular 341.41
-
Fòrmula C18H23N5O2
-
SMILES
O=C(NC1=NC=NC(N2CCCCC2)=C1)NC3=CC(C)=CC=C3OC
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Gudala S, et al. Identification and Pharmacological Analysis of High Efficacy Small Molecule Inhibitors of EGF-EGFR Interactions in Clinical Treatment of Non-Small Cell Lung Carcinoma: a Computational Approach. Asian Pacific journal of cancer prevention : APJCP. 2015;16(18):8191-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)